| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | |
| Div Cover | n/a | |
| Op Mrgn | 1.4% | |
| ROCE | 9.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | 656.6 | |
| PEG | n/a | |
| Pr/Revenue | 4.8 | |
| Pr/Book | 5.8 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 14.8% | |
| PBT | -62.0% | |
| EPS | -94.0% | |
| DPS | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 2,666.70 | (232.22) | (136.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
| 31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
| 31-Dec-24 | 4,241.22 | 316.63 | 16.00¢ | 431.7 | n/a | -94% | n/a | 0.0% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 4,971.56 | 1,628.64 | 684.37¢ | 15.4 | 0.0 | +4,177% | n/a | 0.0% |
| 31-Dec-26 | 5,522.32 | 1,936.05 | 787.77¢ | 13.3 | 0.9 | +15% | n/a | 0.0% |
| 31-Dec-27 | 6,054.94 | 2,242.22 | 883.52¢ | 11.9 | 1.0 | +12% | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 101.99 |
| Change Today | $ -3.07 |
| % Change | -2.92 % |
| 52 Week High | $110.57 |
| 52 Week Low | $55.11 |
| Volume | 2,360,758 |
| Shares Issued | 193.43m |
| Market Cap | $19,728m |
| RiskGrade | 196 |
| Strong Buy | 7 |
| Buy | 5 |
| Neutral | 10 |
| Sell | 2 |
| Strong Sell | 0 |
| Total | 24 |

| Time | Volume / Share Price |
| 16:00 | 450,868 @ $101.99 |
| 15:59 | 100 @ $102.00 |
| 15:59 | 100 @ $101.99 |
| 15:59 | 800 @ $101.98 |
| 15:59 | 100 @ $101.97 |
You are here: research